Deletion (20q) as the sole abnormality in Waldenström macroglobulinemia suggests distinct pathogenesis of 20q11 anomaly

Cancer Genetics and Cytogenetics

Volumn 169, Issue 1, 2006, Pages 69-72

  Liu, Yi Chang ^a,b   Miyazawa, Keisuke ^a   Sashida, Goro ^a   Kodama, Atsushi ^a   Ohyashiki, Kazuma ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

MELPHALAN; PREDNISOLONE;

ACUTE GRANULOCYTIC LEUKEMIA; AGED; ARTICLE; CASE REPORT; CHROMOSOME 20Q; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME DELETION 20Q; CLINICAL FEATURE; DISEASE COURSE; HUMAN; LABORATORY TEST; MALE; MYELODYSPLASTIC SYNDROME; PATHOGENESIS; PHYSICAL EXAMINATION; PLASMA CELL DYSCRASIA; PRIORITY JOURNAL; SPECTRAL KARYOTYPING; WALDENSTROEM MACROGLOBULINEMIA;

AGED; AGED, 80 AND OVER; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 20; FEMALE; HUMANS; KARYOTYPING; MALE; WALDENSTROM MACROGLOBULINEMIA;

EID: 33746255932     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2006.03.013     Document Type: Article

References (16)

1. Greenberg P., Cox C., LeBeau M.M., Fenaux P., Morel P., Sanz G., Sanz M., Vallespi T., Hamblin T., Oscier D., Ohyashiki K., Toyama K., Aul C., Mufti G., and Bennett J. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89 (1997) 2079-2088
2. Mitelman F, Johansson B, Mertens F, editors. Mitelman database of chromosome aberrations in cancer [Internet]. Updated November 2005. Available from: http://cgap.nci.nih.gov/Chromosomes/Mitelman. Accessed January 29, 2006.
3. Nilsson T., Nilsson L., Lenhoff S., Rylander L., Astrand-Grundstrom I., Strombeck B., Hoglund M., Turesson I., Westin J., Mitelman F., Jacobsen S.E., and Johansson B. MDS/AML-associated cytogenetic abnormalities in multiple myeloma and monoclonal gammopathy of undetermined significance: evidence for frequent de novo occurrence and multipotent stem cell involvement of del(20q). Genes Chromosomes Cancer 41 (2004) 223-231
4. Johansson B., Mertens F., Heim S., Kristoffersson U., and Mitelman F. Cytogenetics of secondary myelodysplasia (sMDS) and acute nonlymphocytic leukemia (sANLL). Eur J Haematol 47 (1991) 17-27
5. Beauchamp-Nicoud A., Feneux D., Bayle C., Bernheim A., Leonard C., Koscielny S., Tchernia G., and Bourhis J.H. Therapy-related myelodysplasia and/or acute myeloid leukaemia after autologous haematopoietic progenitor cell transplantation in a prospective single centre cohort of 221 patients. Br J Haematol 122 (2003) 109-117
6. Blann M.M., Velagaleti G.V., Morgan D.L., Martinez R.E., Conlin P.A., and Tonk V.S. Interstitial deletion of 20q in a patient with Waldenström macroglobulinemia following chemotherapy. Cancer Genet Cytogenet 132 (2002) 145-148
7. Calasanz M.J., Cigudosa J.C., Odero M.D., Ferreira C., Ardanaz M.T., Fraile A., Carrasco J.L., Sole F., Cuesta B., and Gullon A. Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: primary breakpoints and clinical correlations. Genes Chromosomes Cancer 18 (1997) 84-93
8. Bergsagel P.L., and Kuehl W.M. Molecular pathogenesis and a consequent classification of multiple myeloma. J Clin Oncol 23 (2005) 6333-6338
9. Bergsagel P.L., Kuehl W.M., Zhan F., Sawyer J., Barlogie B., and Shaughnessy Jr. J. Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma. Blood 106 (2005) 296-303
10. Fonseca R., Barlogie B., Bataille R., Bastard C., Bergsagel P.L., Chesi M., Davies F.E., Drach J., Greipp P.R., Kirsch I.R., Kuehl W.M., Hernandez J.M., Minvielle S., Pilarski L.M., Shaughnessy Jr. J.D., Stewart A.K., and Avet-Loiseau H. Genetics and cytogenetics of multiple myeloma: a workshop report. Cancer Res 64 (2004) 1546-1558
11. Kuehl W.M., and Bergsagel P.L. Multiple myeloma: evolving genetic events and host interactions. Nat Rev Cancer 2 (2002) 175-187
12. Bergsagel P.L., and Kuehl W.M. Chromosome translocations in multiple myeloma. Oncogene 20 (2001) 5611-5622
13. Hanamura I., Iida S., Akano Y., Hayami Y., Kato M., Miura K., Harada S., Banno S., Wakita A., Kiyoi H., Naoe T., Shimizu S., Sonta S.I., Nitta M., Taniwaki M., and Ueda R. Ectopic expression of MAFB gene in human myeloma cells carrying (14;20)(q32;q11) chromosomal translocations. Jpn J Cancer Res 92 (2001) 638-644
14. Bench A.J., Nacheva E.P., Hood T.L., Holden J.L., French L., Swanton S., Champion K.M., Li J., Whittaker P., Stavrides G., Hunt A.R., Huntly B.J., Campbell L.J., Bentley D.R., Deloukas P., Green A.R., and UK Cancer Cytogenetics Group (UKCCG). Chromosome 20 deletions in myeloid malignancies: reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genes. Oncogene 19 (2000) 3902-3913
15. Wang P.W., Eisenbart J.D., Espinosa III R., Davis E.M., Larson R.A., and Le Beau M.M. Refinement of the smallest commonly deleted segment of chromosome 20 in malignant myeloid diseases and development of a PAC-based physical and transcription map. Genomics 67 (2000) 28-39
16. White N.J., Nacheva E., Asimakopoulos F.A., Bloxham D., Paul B., and Green A.R. Deletion of chromosome 20q in myelodysplasia can occur in a multipotent precursor of both myeloid cells and B cells. Blood 83 (1994) 2809-2816